VO₂max

Definition unit mL·kg⁻¹·min⁻¹ Normalized to body mass for cross-individual comparison

1-MET increase → mortality ↓ 13% All-cause mortality reduction per 1 MET gain (Kodama et al., JAMA 2009)

Elite vs. low fitness HR mortality 5× Hazard ratio comparing bottom to elite fitness quintile (Mandsager et al., 2018)

Primary limiting factor Q̇max Maximal cardiac output drives ~70–75% of VO₂max limitation

Heritability 40–60% Twin and family studies; trainability itself is also heritable

Optimal GXT duration 8–12 min Buchfuhrer et al., 1983; longer tests introduce non-cardiorespiratory limiting factors

01 — Overview

What VO₂max measures and why it matters

A century of evidence from Hill & Lupton (1923) to Mandsager et al. (2018) — the oxygen ceiling as the most consequential biomarker in longevity medicine.

The Oxygen Transport Chain

VO₂max quantifies the highest rate at which oxygen can be taken up, transported, and utilized during severe whole-body exercise. It represents the integrated capacity of seven physiological steps from pulmonary ventilation to mitochondrial oxidative phosphorylation.

7 steps in the oxygen cascade, any of which can limit flux

Central Determinants

Cardiac output (Q̇max = HRmax × SVmax) is the single most important determinant. Elite endurance athletes achieve cardiac outputs of 35–40 L·min⁻¹ versus 20–25 L·min⁻¹ in untrained individuals — driven almost entirely by superior stroke volume, not heart rate.

200 mL stroke volume per beat in elite athletes vs. 100–120 mL untrained

Peripheral Determinants

The arteriovenous oxygen difference reflects peripheral extraction capacity. Trained individuals extract 75–85% of arterial oxygen at maximal exercise (15–17 mL/100 mL), driven by enhanced capillary density, mitochondrial volume density, and oxidative enzyme activity.

75–85% O₂ extraction at max in trained vs. ~25% at rest

Clinical Vital Sign

The American Heart Association's 2016 scientific statement called for CRF to be routinely assessed as a clinical vital sign — alongside blood pressure, heart rate, and BMI. Low CRF confers mortality risk comparable to or exceeding smoking, diabetes, and hypertension.

2016 AHA statement: CRF as a clinical vital sign (Ross et al.)

Historical Milestones

One century of landmark discoveries — from Hill's oxygen ceiling to the AHA vital sign designation.

1923

Hill & Lupton — The Oxygen Ceiling

Described the "oxygen intake ceiling" — a plateau despite further increases in workload. Proposed cardiovascular system as primary limit. Laid groundwork for VO₂max as a measurable construct.

1955

Taylor et al. — Plateau Criterion Formalized

Operationally defined the VO₂ plateau as an increase of less than 150 mL·min⁻¹ (or 2.1 mL·kg⁻¹·min⁻¹) with a workload increase — establishing the classical criterion for VO₂max verification.

1964

Wasserman & McIlroy — Anaerobic Threshold

First systematic description of the ventilatory anaerobic threshold in cardiac patients. Proposed non-invasive gas exchange as a marker of metabolic transition — establishing the foundation for CPET.

1967

Holloszy — Mitochondrial Trainability

First demonstration that endurance training produces near-doubling of mitochondrial enzyme activity in skeletal muscle. Established that peripheral oxidative capacity is highly trainable, independent of central adaptations.

1968

Saltin et al. — Dallas Bed Rest Study

20 days of bed rest reduced VO₂max by an average of 27%, driven primarily by reductions in stroke volume and cardiac output. Subsequent training restored and exceeded baseline — confirming cardiac output primacy.

1986

Beaver, Wasserman & Whipp — V-Slope Method

Introduced the V-slope method for VT1 determination — plotting VCO₂ against VO₂ to identify the breakpoint where excess CO₂ from bicarbonate buffering appears. Remains the preferred clinical method.

1999

Bouchard et al. — HERITAGE Family Study

Standardized 20-week training produced VO₂max improvements ranging from less than 5% to more than 40% in different individuals. Trainability itself is heritable; heritability of VO₂max estimated at 40–60%.

2002

Myers et al. — Exercise Capacity vs. All Risk Factors

In 6,213 men referred for exercise testing, exercise capacity was the strongest predictor of mortality among all clinical variables. Each 1-MET increase conferred 12% improved survival (New England Journal of Medicine).

2007

Wisløff et al. — HIIT in Heart Failure

4×4 HIIT protocol produced superior cardiovascular benefits versus moderate continuous training in heart failure patients — extending HIIT validation into clinical populations and cementing the 4×4 protocol as a gold standard.

2009

Kodama et al. — JAMA Meta-Analysis

102,980 participants across 33 studies. Each 1-MET increase associated with 13% reduction in all-cause mortality and 15% reduction in cardiovascular events. Established the dose-response relationship at population scale.

2016

AHA — CRF as Clinical Vital Sign

Ross, Blair, Arena et al. published landmark scientific statement calling for CRF to be assessed and reported as a clinical vital sign in all patients. Proposed that CRF provides independent prognostic information beyond traditional risk factors.

2018

Mandsager et al. — No Upper Benefit Threshold

122,007 patients at Cleveland Clinic. Elite fitness (≥97.7th percentile) still associated with lower mortality than high fitness — no U-shaped curve. Hazard ratio: 5.04 comparing lowest to elite fitness group. Published in JAMA Network Open.

02 — Physiology & Determinants

The Fick Equation: Central and Peripheral Determinants

VO₂max is the product of maximal cardiac output and the maximal arteriovenous oxygen difference — a two-factor model governing the oxygen transport chain from lungs to mitochondria.

VO₂max = Q̇max × (CaO₂ − CvO₂)max

Q̇max = maximal cardiac output (L·min⁻¹) · CaO₂ = arterial O₂ content · CvO₂ = mixed venous O₂ content
The difference (CaO₂ − CvO₂) = maximal arteriovenous oxygen difference (a-vO₂ diff)

The Oxygen Transport Cascade — Atmosphere to Mitochondria

STEP 1–2

Pulmonary Ventilation & Diffusion

VE, tidal volume, DLCO — generally non-limiting except in elite athletes (EIAH) and altitude

STEP 3–4 · CENTRAL · 70–75% of limitation

Cardiac Output + Hemoglobin Loading

Q̇ = HR × SV · Primary limiting factor in healthy individuals (Bassett & Howley, 2000)

STEP 5–7 · PERIPHERAL · 25–30% of limitation

Blood Flow Distribution + Mitochondria

Capillary density, peripheral O₂ diffusion, mitochondrial oxidative enzymes · a-vO₂ diff

OUTPUT

VO₂max → Fitness → ↓ Mortality

Central Factors

Cardiac Maximal Cardiac Output (Q̇max)

▼

The primary determinant in healthy individuals. Q̇max = HRmax × SVmax. Untrained: 20–25 L·min⁻¹. Elite endurance athletes: 35–40 L·min⁻¹ or higher. Bjørn Dæhlie reportedly exceeded 40 L·min⁻¹.

Training-induced gains come almost entirely from stroke volume increases, not heart rate. HRmax is not significantly altered by endurance training and declines ~0.7 bpm/year with age.

Mechanisms: eccentric cardiac hypertrophy (increased LV end-diastolic volume), plasma volume expansion (+10–20%), enhanced diastolic filling, improved myocardial contractility.

Hematology Hemoglobin & Oxygen-Carrying Capacity

▼

CaO₂ = (Hb × 1.34 × SaO₂) + (0.003 × PaO₂). Hemoglobin concentration is critical. Blood doping and EPO administration increase VO₂max by 5–10% by elevating Hb concentration (Ekblom et al., 1976; Lundby et al., 2012).

Anemia significantly reduces VO₂max. At altitude, reduced PIO₂ limits SaO₂ — VO₂max falls ~6–7% per 1,000 m above 1,500 m elevation (Wehrlin & Hallén, 2006).

Pulmonary Pulmonary Function & Gas Exchange

▼

In healthy individuals at sea level, pulmonary function is generally not limiting. SaO₂ typically remains above 95% even at maximal exercise.

Exception — EIAH: In ~40–50% of elite endurance athletes at maximal exercise, transit time through pulmonary capillaries becomes insufficient for complete O₂ equilibration — SaO₂ can drop below 92–93%, making lungs a genuine constraint (Dempsey & Wagner, 1999).

Also limiting in COPD, interstitial lung disease, and pulmonary vascular disease — where ventilatory constraints become primary exercise limiters.

Peripheral Factors

Vascular Capillary Density

▼

Endurance training increases capillary-to-fiber ratio via angiogenesis (Andersen & Henriksson, 1977). Higher capillary density increases O₂ diffusion surface area, reduces mean diffusion distance, and increases red cell transit time — allowing more complete O₂ unloading.

Cellular Mitochondrial Content & Oxidative Enzymes

▼

Holloszy (1967) demonstrated near-doubling of mitochondrial enzyme activity with endurance training. Mitochondrial volume density can increase 50–100% or more with training; citrate synthase, succinate dehydrogenase, and cytochrome c oxidase all increase substantially.

Critical nuance: Mitochondrial capacity typically exceeds the cardiovascular system's ability to supply oxygen. This means mitochondrial adaptation is more critical for threshold performance and economy than for VO₂max per se — cardiac output remains the bottleneck (Bassett & Howley, 2000).

Structural Muscle Fiber Type

▼

Type I (slow-twitch) fibers: higher mitochondrial density, greater capillary supply, higher myoglobin content. Individuals with higher Type I fiber proportion in locomotor muscles tend toward higher VO₂max and superior endurance performance (Costill et al., 1976).

Fiber type distribution is largely genetically determined, but endurance training can shift expression (Type IIx → Type IIa) and enhance oxidative capacity of all fiber types.

Wagner's Integrated Model (1996, 2000): VO₂max is not limited by any single step but by the integrated conductance of the entire oxygen transport pathway. Under sea-level conditions, approximately 70–75% of limitation resides in convective delivery steps (cardiac output + blood oxygen content), with 25–30% in peripheral diffusive steps. The relative balance shifts at altitude, with small muscle mass exercise, and in cardiac failure.

03 — Testing & Technology

Graded Exercise Testing: Protocols, Technology, and Criteria

From Douglas bags to breath-by-breath metabolic carts — the methodology for measuring the gold standard of aerobic capacity.

Protocol	Modality	Structure	VO₂max Yield	Best Used For	Limitations
Bruce Protocol	Treadmill	3-min stages; speed + grade increase simultaneously	High	Clinical screening; cardiac populations; decades of normative data	Large inter-stage increments; poor threshold resolution; may cause premature termination in less fit individuals
Balke Protocol	Treadmill	Constant speed (3.3 mph); 1% grade increase per minute	High	Gradual, linear workload increase; good threshold determination	Long duration for very fit subjects; less used clinically
Ramp Protocol	Treadmill / Cycle	Continuous linear increase in workload over time	Highest	CPET; precise threshold determination; research; individualized testing	Requires individualized ramp rate selection; more complex protocol design
Cycle Ergometer	Cycle	Progressive watt increments; 3-min or ramp stages	5–15% lower than treadmill	Clinical populations; precise workload quantification; ECG monitoring; upper body stability	Quadriceps fatigue limits performance before cardiovascular exhaustion in non-cyclists; lower muscle mass engaged

Optimal GXT Duration: Tests should be individualized to aim for 8–12 minutes duration (Buchfuhrer et al., 1983). Tests shorter than 6 minutes may not allow physiological responses to fully develop. Tests longer than 15 minutes introduce non-cardiorespiratory limiting factors (thermoregulation, musculoskeletal fatigue, motivation).

Breath-by-Breath Gas Analysis

Components of a modern metabolic cart and the Haldane transformation underlying all VO₂ calculations.

Flow Sensor

Measures volume and flow rate of inspired and expired air. Technologies: Pitot tube pneumotachographs, turbine flow meters, hot-wire anemometers, ultrasonic sensors. Accurate flow measurement is critical — errors directly propagate into VO₂ and VCO₂ calculations.

Gas Analyzers

O₂: paramagnetic analyzers (most accurate), galvanic fuel cells, zirconia cells. CO₂: non-dispersive infrared (NDIR) or photoacoustic analyzers. For breath-by-breath: response time must be <100 ms for 90% response to track rapid concentration changes within each breath.

Calibration Requirements

Gas calibration with certified reference gases before each test. Volume calibration with precision 3L syringe across flow range. Delay time verification for sampling line transit. Biological validation (testing known subject under standardized conditions) recommended periodically.

The Haldane Transformation

V_I = V_E × (FE_N₂ / FI_N₂) // Nitrogen inert; derive inspired volume from expired

VO₂ = (V_I × FI_O₂) − (V_E × FE_O₂) // Oxygen consumption per breath

VCO₂ = (V_E × FE_CO₂) − (V_I × FI_CO₂) // CO₂ production per breath

All volumes corrected to STPD (Standard Temperature, Pressure, Dry) conditions. Delay time correction aligns gas concentration signal with flow signal.

Criteria for True VO₂max

The classical plateau criterion is not universally observed — only 30–70% of subjects demonstrate it. Secondary and verification criteria are routinely applied.

Primary VO₂ Plateau Criterion (Taylor et al., 1955)

▼

Increase in VO₂ of less than 150 mL·min⁻¹ (or 2.1 mL·kg⁻¹·min⁻¹) with an increase in workload. The classical criterion first described by Hill & Lupton (1923) and formalized by Taylor et al. (1955).

Limitation: Observed in only 30–70% of subjects depending on protocol and population. Cannot be required as an absolute criterion in clinical testing (Howley et al., 1995; Poole & Jones, 2017).

Secondary Secondary Criteria for Maximal Effort

▼

RER ≥ 1.10–1.15: CO₂ production exceeds O₂ consumption, reflecting significant anaerobic metabolism and bicarbonate buffering.

Heart rate within 10 bpm of age-predicted HRmax: Suggests near-maximal cardiovascular effort (≥90% of 220 − age).

Blood lactate ≥ 8–10 mmol·L⁻¹: Post-exercise confirmation of substantial anaerobic glycolysis.

RPE ≥ 17–19 on Borg 6–20 scale: Subjective confirmation of near-maximal effort.

Gold Standard Supramaximal Verification Protocol

▼

After the incremental test and 5–15 minutes of recovery, the subject performs a constant-load bout at 105–110% of peak workload to exhaustion. If VO₂ during the verification bout does not exceed the incremental test VO₂max (difference <3% or <150 mL·min⁻¹), the incremental test value is confirmed as true VO₂max.

Considered the current gold standard for VO₂max confirmation (Poole & Jones, 2017; Nolan et al., 2014).

Distinction VO₂max vs. VO₂peak

▼

VO₂peak: Highest oxygen uptake achieved during a particular test — may or may not represent the subject's true physiological maximum.

Used in clinical populations where exercise is limited by symptoms (dyspnea, angina, claudication) before true cardiovascular exhaustion. The prognostic value of VO₂peak is well-established regardless of whether a true plateau is demonstrated (Poole & Jones, 2017).

04 — Ventilatory & Lactate Thresholds

The Metabolic Transition Points

VT1, VT2, LT1, OBLA, and MLSS — the physiological inflection points that define the exercise intensity spectrum and guide precision training prescription.

VT1 — First Ventilatory Threshold

Also: Aerobic Threshold · Gas Exchange Threshold (GET) · Ventilatory Anaerobic Threshold (VAT). The exercise intensity at which VE increases disproportionately relative to VO₂ — reflecting onset of bicarbonate buffering of accumulating lactate.

TYPICAL OCCURRENCE

45–65% VO₂max (untrained)

65–80% VO₂max (trained)

VT2 — Second Ventilatory Threshold

Also: Respiratory Compensation Point (RCP). VE increases disproportionately relative to both VO₂ and VCO₂ — reflecting hyperventilation to compensate for overwhelming metabolic acidosis. Upper boundary of the heavy exercise domain; entry into severe intensity.

TYPICAL OCCURRENCE

60–80% VO₂max (untrained)

80–92% VO₂max (trained)

Methods of Threshold Determination

Method	Threshold	Signal	VT1 Marker	VT2 Marker	Strengths
V-Slope	VT1 (primary)	VCO₂ vs. VO₂ plot	Upward slope change (breakpoint) — excess CO₂ from HCO₃⁻ buffering	—	Relatively independent of ventilatory pattern; less affected by hyperventilation artifact; good agreement with LT1 (Beaver et al., 1986)
Ventilatory Equivalents	VT1 + VT2	VE/VO₂ and VE/VCO₂ vs. time	VE/VO₂ increases while VE/VCO₂ remains stable or decreases	VE/VCO₂ also begins to increase systematically	Most widely used in clinical CPET; clearly identifies both thresholds; described by Wasserman et al. (1973)
End-Tidal Gas Pressures	VT1 + VT2	PETO₂ and PETCO₂ vs. time	PETO₂ increases; PETCO₂ remains stable or slightly increases	PETCO₂ begins to decrease (hyperventilation drives down alveolar PCO₂)	Excellent confirmatory approach; particularly clear PETCO₂ inflection at VT2
Excess CO₂	VT1	ExCO₂ = VCO₂ − (RERbaseline × VO₂)	First increase in excess CO₂ above baseline aerobic RER	—	Directly quantifies non-metabolic CO₂ from bicarbonate buffering; sensitive to early threshold

Lactate-Based Thresholds

Invasive blood sampling provides direct measurement of lactate kinetics — the underlying driver of ventilatory threshold responses.

LT1 Lactate Threshold 1 (LT1 / First Lactate Turn Point)

▼

First sustained increase in blood lactate above baseline resting levels (typically 0.5–1.5 mmol·L⁻¹). Operationally defined as an increase of 0.5–1.0 mmol·L⁻¹ above baseline or the first breakpoint in the lactate-workload curve.

Corresponds physiologically to VT1 — reflects the onset of lactate accumulation triggering the bicarbonate buffering cascade. Multiple studies confirm good agreement between VT1 and LT1 (Davis et al., 1976; Wasserman et al., 2012).

OBLA Onset of Blood Lactate Accumulation (OBLA) — 4 mmol·L⁻¹

▼

Defined as the exercise intensity corresponding to a fixed blood lactate of 4 mmol·L⁻¹ (Sjödin & Jacobs, 1981; Heck et al., 1985). Widely used in sport science for training prescription and performance prediction.

Critical limitation: The 4 mmol·L⁻¹ value is arbitrary and does not account for individual variation. Some individuals reach their MLSS at concentrations well below or above 4 mmol·L⁻¹. Despite limitations, OBLA remains a practical reference point (Faude et al., 2009).

MLSS Maximal Lactate Steady State (MLSS) — Gold Standard

▼

Highest exercise intensity at which blood lactate remains stable over time during constant-load exercise — the boundary between heavy and severe intensity domains. Gold standard for prescribing the upper limit of sustainable training.

MLSS blood lactate concentration: approximately 2.5–5.5 mmol·L⁻¹ with considerable inter-individual variation (Beneke et al., 2011). This range underscores why 4 mmol·L⁻¹ is inadequate as a universal threshold.

Practical constraint: Determination requires multiple 30-minute constant-load bouts on separate days — impractical for routine testing. Single-test estimation methods (Dmax, modified Dmax) have been developed as approximations.

Convergence of Ventilatory and Lactate Thresholds: VT1 ≈ LT1 (onset of lactate accumulation) · VT2/RCP ≈ LT2/OBLA ≈ MLSS (upper boundary of sustainable intensity). The physiological link is bicarbonate buffering: accumulating lactate → H⁺ + HCO₃⁻ → H₂CO₃ → H₂O + CO₂ (excess). This excess CO₂ drives the ventilatory responses detected non-invasively as the ventilatory thresholds.

05 — Training Applications

From Thresholds to Zone Prescription

Threshold-based zones reflect actual metabolic transitions — unlike arbitrary percentage-based systems. Evidence for polarized training, HIIT protocols, and the physiology of endurance performance.

Training Zone Models

LOW INTENSITY ← VT1 → ← VT2/RCP → HIGH INTENSITY

ZONE 1

Recovery / Easy

<75–80% of VT1 HR

Active recovery, basic aerobic conditioning. Fat oxidation maximal. Conversation easy. Sustainable for hours.

ZONE 2

Aerobic Base

80–100% of VT1 HR

Mitochondrial biogenesis, fat oxidation, capillary density, cardiac adaptations. "Just below to at VT1."

ZONE 3

Tempo

Between VT1 and VT2

Lactate clearance capacity, sustained power at moderate intensity. Significant fatigue without maximal adaptation signal.

ZONE 4

Threshold

At or above VT2/RCP

VO₂max improvement, lactate tolerance, cardiac output enhancement. 90–95% HRmax HIIT intervals most effective.

ZONE 5

Anaerobic

Near-maximal to supramaximal

Anaerobic capacity, neuromuscular power, speed. Duration severely limited. Not the primary VO₂max stimulus.

Polarized Training: The Evidence

Elite endurance athletes across multiple sports distribute ~75–80% of training volume below VT1, ~15–20% above VT2, and less than 5–10% in the moderate Zone 3 "no man's land."

Stöggl & Sperlich (2014) — Frontiers in Physiology: Compared four training distributions (polarized, threshold, high-volume low-intensity, HIIT) in well-trained endurance athletes over 9 weeks. The polarized group showed the greatest improvements in VO₂max, time to exhaustion, and peak power output — providing direct experimental evidence for the superiority of the polarized model.

Low Intensity (Zone 1) Rationale

High volume aerobic stimulus drives mitochondrial biogenesis, capillary growth, and cardiac adaptations with minimal accumulated fatigue and low injury risk. The foundation layer — disproportionately high training time relative to perceived intensity.

High Intensity (Zone 3+) Rationale

Potent stimulus for VO₂max improvement, cardiac output enhancement, and lactate tolerance. Helgerud et al. (2007): only the 4×4 HIIT group showed significant VO₂max improvement (+7.2%) — the long slow distance and lactate threshold groups did not.

Zone 3 "No Man's Land"

Moderate intensity generates significant fatigue without providing sufficiently strong stimulus for either aerobic base development or VO₂max improvement. Too hard to be easy, too easy to be hard. Elite athletes minimize time here — typically <5–10% of weekly volume.

The 4×4 HIIT Protocol

The most extensively validated protocol for VO₂max improvement — developed at the Norwegian University of Science and Technology by Wisløff and colleagues.

Variable	Specification
Interval duration	4 minutes
Interval intensity	90–95% HRmax
Number of intervals	4 repetitions
Recovery duration	3 minutes active recovery
VO₂max improvement (8 wk)	+7.2%
Stroke volume change	Significant increase
Key reference	Helgerud et al., 2007

Helgerud et al. (2007) — Med Sci Sports Exerc: Compared 4 training protocols over 8 weeks in moderately trained men. Long slow distance and lactate threshold training produced no significant VO₂max increase. The 15/15 and 4×4 HIIT groups both improved VO₂max — with 4×4 producing 7.2% improvement, accompanied by significant stroke volume increase.

Wisløff et al. (2007) — Circulation: Extended 4×4 HIIT validation to heart failure patients. Superior cardiovascular effects versus moderate continuous training — confirming protocol utility in clinical populations and cementing the Norwegian method's evidence base.

The Three Determinants of Endurance Performance

Joyner & Coyle (2008): VO₂max sets the ceiling, but threshold and economy determine how much of that ceiling can be sustained.

The ceiling of aerobic capacity. Sets the absolute upper limit for sustained oxidative power output. Primary driver: maximal cardiac output. Improved most effectively via HIIT at 90–95% HRmax.

Lactate Threshold (%VO₂max)

The sustainable fraction of the ceiling. Two athletes with identical VO₂max can differ substantially in performance if one sustains a higher percentage without lactate accumulation. Trained via threshold work at Zone 3.

Exercise Economy

The oxygen cost of locomotion at a given speed or power output. Superior economy allows the same VO₂max to translate into faster running or higher power. Influenced by biomechanics, fiber type, and mitochondrial efficiency.

06 — Aging & Decline

The Age-Related Decline in VO₂max

One of the most consistent physiological changes with aging — with profound implications for functional independence and longevity planning.

Decline rate (20s–60s) ~5–10% Per decade — cross-sectional estimates (Hawkins & Wiswell, 2003)

Decline rate (after 70) >20% Per decade — accelerating rate in older adults (Fleg et al., 2005)

HRmax decline rate 0.7 bpm/yr Tanaka et al. (2001): HRmax ≈ 208 − 0.7 × age

Functional independence threshold ~15–18 mL·kg⁻¹·min⁻¹ (~4–5 METs) — below this, daily activities become compromised

Training adaptation (older adults) +10–25% VO₂max improvement achievable even from previously sedentary baseline

Lifelong athletes advantage 30–50% Higher VO₂max than sedentary age-matched peers (Trappe et al., 2013)

VO₂max Trajectory: Trained vs. Untrained · Illustrative Decline Curves

Illustrative curves based on Fleg et al. (2005), Trappe et al. (2013), Hawkins & Wiswell (2003). Values approximate.

Mechanisms of Age-Related Decline

Central Reduced Maximal Heart Rate & Stroke Volume

▼

HRmax declines approximately 0.7 beats per minute per year (Tanaka et al., 2001) — more accurately modeled as HRmax ≈ 208 − 0.7 × age. This reduces maximal cardiac output regardless of stroke volume.

Age-related reductions in maximal stroke volume: myocardial compliance decreases, arterial stiffness increases, blood volume decreases — all reducing preload and stroke volume at maximal exercise.

Peripheral Sarcopenia, Mitochondrial Decline & Capillary Loss

▼

Sarcopenia: Loss of skeletal muscle mass reduces total peripheral oxidative capacity and the metabolic demand driving cardiac output. Accelerates after age 50–60.

Mitochondrial decline: Aging is associated with reductions in mitochondrial volume density and oxidative enzyme activity — reducing the capacity to extract and utilize oxygen even when delivered.

Reduced capillary density: Age-related reductions in muscle capillarization impair both peripheral O₂ delivery and extraction capacity.

Composition Increased Body Fat — Relative VO₂max Effect

▼

Age-related increases in adiposity reduce relative VO₂max (mL·kg⁻¹·min⁻¹) even when absolute VO₂max (L·min⁻¹) is partially maintained. This dual-mechanism decline — both absolute and relative — accelerates the functional impact of aging.

The Attia Principle on Longevity Margin: Maintaining a high VO₂max throughout life provides a reserve of functional capacity that buffers against the inevitable age-related decline and preserves independence into the ninth and tenth decades. The functional threshold of ~15–18 mL·kg⁻¹·min⁻¹ (~4–5 METs) marks the boundary below which basic daily activities become compromised. The higher the VO₂max peak, the longer one can decline before crossing it (Attia, 2023; Paterson et al., 1999).

07 — Clinical Evidence

Cardiorespiratory Fitness as a Vital Sign

The strongest modifiable predictor of mortality — with a dose-response relationship extending to the highest fitness levels and no upper threshold of benefit.

All-cause mortality reduction per 1 MET 13% 102,980 participants · 33 studies · Kodama et al., JAMA 2009

CVD event reduction per 1 MET 15% Same meta-analysis · graded dose-response across all fitness levels

Elite vs. lowest fitness HR 5.04× Hazard ratio for mortality · 122,007 patients · Mandsager et al., JAMA Network Open 2018

VO₂peak threshold for transplant listing <14 mL·kg⁻¹·min⁻¹ (heart failure) · <12 if on beta-blockers · Mancini et al., 1991

Landmark Studies

Kodama et al. · JAMA · 2009

Meta-analysis: CRF above 7.9 METs — lower all-cause mortality and CVD risk

Pooled 33 studies, 102,980 participants. Graded, remarkably consistent dose-response relationship across studies. Individuals above 7.9 METs showed significantly lower risk of all-cause mortality and coronary heart disease/cardiovascular events.

13% mortality reduction per 1-MET gain

Mandsager et al. · JAMA Network Open · 2018

No upper benefit threshold — elite fitness still protective vs. high fitness

122,007 patients; median follow-up 8.4 years at Cleveland Clinic. CRF inversely associated with all-cause mortality across entire fitness spectrum with no upper limit of benefit. Even elite fitness (≥97.7th percentile) outperformed high fitness (75th–97.6th percentile).

5.04× HR comparing lowest to elite fitness (95% CI: 4.10–6.20)

Myers et al. · NEJM · 2002

Exercise capacity strongest predictor of mortality — surpassing all traditional risk factors

6,213 men referred for exercise testing. Exercise capacity was the strongest predictor of mortality among all clinical and exercise test variables — more powerful than hypertension, diabetes, or ECG findings.

12% improved survival per 1-MET increase

Kokkinos et al. · Circulation · 2008, 2010

Graded inverse association confirmed across race, sex, and age

18,102 male Veterans Affairs patients; extended findings to women, African Americans, and patients with comorbidities. Each 1-MET increase associated with 12% mortality risk reduction. 20-year follow-up in older men confirmed sustained protective effect.

12% mortality risk reduction per 1 MET in Veterans cohort

Ross et al. · Circulation · 2016

AHA designates CRF as a clinical vital sign

AHA scientific statement by Ross, Blair, Arena et al. called for CRF to be routinely assessed and reported alongside blood pressure, heart rate, and BMI. Argued CRF provides independent and additive prognostic information beyond all traditional risk factors and is modifiable through exercise training.

2016 AHA vital sign designation — paradigm shift in preventive medicine

Fleg et al. · Circulation · 2005

Rate of VO₂max decline accelerates markedly after age 70

Longitudinal Baltimore study, 810 healthy volunteers. VO₂max decline: ~3–6% per decade in 20s–30s, accelerating to over 20% per decade after age 70. Attributed to reductions in both maximal cardiac output and maximal a-vO₂ difference.

>20% per decade decline after age 70

CRF in Clinical Practice

Clinical Context	VO₂ Metric Used	Critical Threshold	Application
Heart Failure	VO₂peak (mL·kg⁻¹·min⁻¹)	<14 mL·kg⁻¹·min⁻¹ (<12 on β-blockers)	Key criterion for cardiac transplantation listing. Best predictor of prognosis in ambulatory heart failure (Mancini et al., 1991).
Preoperative Risk Assessment	VO₂peak + anaerobic threshold	VO₂peak <11 mL·kg⁻¹·min⁻¹ or AT <11	Associated with increased perioperative morbidity and mortality. CPET increasingly standard for major surgery in older adults with comorbidities (Older et al., 1999).
Pulmonary Disease (COPD/PH)	VO₂peak + ventilatory thresholds	Mechanism-specific	CPET differentiates ventilatory vs. cardiovascular vs. peripheral limitation — critical for treatment decision-making and rehabilitation planning.
Preventive / Primary Care	VO₂max (METs) — direct or estimated	7.9 METs threshold (Kodama, 2009)	AHA recommends routine CRF assessment as 5th vital sign. Non-exercise prediction equations (Jurca et al., 2005) make estimation feasible without formal CPET.
Longevity Medicine	VO₂max relative to age/sex norms	Elite fitness (>97.7th percentile)	No upper benefit threshold confirmed (Mandsager, 2018). Target-setting for longevity programs: optimize VO₂max as primary healthspan biomarker alongside other "engine" metrics.

The AHA Statement (Ross et al., 2016): "CRF is a potentially stronger predictor of mortality than established risk factors such as smoking, hypertension, high cholesterol, and type 2 diabetes mellitus." Despite this, CRF assessment remains underutilized in routine clinical practice — barriers include time constraints, equipment availability, reimbursement, and insufficient provider training. Validated non-exercise CRF estimation equations (Jurca et al., 2005) have reduced the barrier to clinical implementation.

Emerging Perspectives

VO₂max and Brain Health

Higher CRF associated with larger hippocampal volume, better white matter integrity, improved executive function, and reduced Alzheimer's risk (Erickson et al., 2011). Mechanisms: exercise-induced BDNF increases, improved cerebrovascular function, reduced neuroinflammation, enhanced neuroplasticity.

Sex Differences

Women typically have VO₂max values 15–30% lower than men of similar age and training status — primarily due to lower hemoglobin, smaller heart and stroke volume, lower muscle mass, and higher body fat. Gap narrows to ~10–15% when expressed relative to lean body mass (Joyner, 2017). Sex-specific reference values are essential for clinical interpretation.

Wearable Estimation

Consumer wearables (smartwatches) increasingly provide estimated VO₂max from heart rate, GPS speed, and proprietary algorithms. Typical error: ±3–5 mL·kg⁻¹·min⁻¹ versus laboratory measurement (Passler et al., 2019). Accuracy limitations acknowledged — but democratization of CRF tracking has population-level awareness value.

Genetics of VO₂max

Heritability: 40–60%. HERITAGE Family Study (Bouchard et al., 1999): identical 20-week training produced VO₂max responses from <5% to >40% improvement in different individuals. Trainability is itself heritable. Genetic variants in mitochondrial biogenesis, angiogenesis, and cardiac function contribute to inter-individual differences.

08 — References

Complete Reference List

71 peer-reviewed sources and texts cited throughout this document. Filterable by topic area, searchable by author, year, or journal.

71 references

Andersen, P., & Henriksson, J. (1977). Capillary supply of the quadriceps femoris muscle of man: Adaptive response to exercise. The Journal of Physiology, 270(3), 677–690.

Peripheral doi.org/10.1113/jphysiol.1977.sp011975

Attia, P. (2023). Outlive: The Science and Art of Longevity. Harmony Books.

Aging

Bassett, D. R., & Howley, E. T. (2000). Limiting factors for maximum oxygen uptake and determinants of endurance performance. Medicine & Science in Sports & Exercise, 32(1), 70–84.

Central doi.org/10.1097/00005768-200001000-00012

Beaver, W. L., Wasserman, K., & Whipp, B. J. (1986). A new method for detecting anaerobic threshold by gas exchange. Journal of Applied Physiology, 60(6), 2020–2027.

Thresholds doi.org/10.1152/jappl.1986.60.6.2020

Beneke, R. (2003). Methodological aspects of maximal lactate steady state—implications for performance testing. European Journal of Applied Physiology, 89(1), 95–99.

Thresholds doi.org/10.1007/s00421-002-0783-1

Beneke, R., Leithäuser, R. M., & Ochentel, O. (2011). Blood lactate diagnostics in exercise testing and training. International Journal of Sports Physiology and Performance, 6(1), 8–24.

Thresholds doi.org/10.1123/ijspp.6.1.8

Blair, S. N., Kampert, J. B., Kohl, H. W., Barlow, C. E., Macera, C. A., Paffenbarger, R. S., & Gibbons, L. W. (1996). Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA, 276(3), 205–210.

Clinical doi.org/10.1001/jama.1996.03540030039029

Bouchard, C., An, P., Rice, T., Skinner, J. S., Wilmore, J. H., Gagnon, J., Pérusse, L., Leon, A. S., & Rao, D. C. (1999). Familial aggregation of VO₂max response to exercise training: Results from the HERITAGE Family Study. Journal of Applied Physiology, 87(3), 1003–1008.

Training doi.org/10.1152/jappl.1999.87.3.1003

Bruce, R. A., Kusumi, F., & Hosmer, D. (1973). Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. American Heart Journal, 85(4), 546–562.

Testing doi.org/10.1016/0002-8703(73)90502-4

10.

Buchfuhrer, M. J., Hansen, J. E., Robinson, T. E., Sue, D. Y., Wasserman, K., & Whipp, B. J. (1983). Optimizing the exercise protocol for cardiopulmonary assessment. Journal of Applied Physiology, 55(5), 1558–1564.

Testing doi.org/10.1152/jappl.1983.55.5.1558

11.

Convertino, V. A. (1991). Blood volume: Its adaptation to endurance training. Medicine & Science in Sports & Exercise, 23(12), 1338–1348.

Central doi.org/10.1249/00005768-199112000-00004

12.

Costill, D. L., Fink, W. J., & Pollock, M. L. (1976). Muscle fiber composition and enzyme activities of elite distance runners. Medicine and Science in Sports, 8(2), 96–100.

Peripheral

13.

Davis, J. A., Vodak, P., Wilmore, J. H., Vodak, J., & Kurtz, P. (1976). Anaerobic threshold and maximal aerobic power for three modes of exercise. Journal of Applied Physiology, 41(4), 544–550.

Thresholds doi.org/10.1152/jappl.1976.41.4.544

14.

Dempsey, J. A., Hanson, P. G., & Henderson, K. S. (1984). Exercise-induced arterial hypoxaemia in healthy human subjects at sea level. The Journal of Physiology, 355(1), 161–175.

Central doi.org/10.1113/jphysiol.1984.sp015412

15.

Dempsey, J. A., & Wagner, P. D. (1999). Exercise-induced arterial hypoxemia. Journal of Applied Physiology, 87(6), 1997–2006.

Central doi.org/10.1152/jappl.1999.87.6.1997

16.

Ekblom, B., & Hermansen, L. (1968). Cardiac output in athletes. Journal of Applied Physiology, 25(5), 619–625.

Central doi.org/10.1152/jappl.1968.25.5.619

17.

Ekblom, B., Wilson, G., & Åstrand, P. O. (1976). Central circulation during exercise after venesection and reinfusion of red blood cells. Journal of Applied Physiology, 40(3), 379–383.

Central doi.org/10.1152/jappl.1976.40.3.379

18.

Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., Wojcicki, T. R., Mailey, E., Vieira, V. J., Martin, S. A., Pence, B. D., Woods, J. A., McAuley, E., & Kramer, A. F. (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences, 108(7), 3017–3022.

Brain Health doi.org/10.1073/pnas.1015950108

19.

Faude, O., Kindermann, W., & Meyer, T. (2009). Lactate threshold concepts: How valid are they? Sports Medicine, 39(6), 469–490.

Thresholds doi.org/10.2165/00007256-200939060-00003

20.

Fleg, J. L., Morrell, C. H., Bos, A. G., Brant, L. J., Talbot, L. A., Wright, J. G., & Lakatta, E. G. (2005). Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation, 112(5), 674–682.

Aging doi.org/10.1161/CIRCULATIONAHA.105.545459

21.

Fox, S. M., Naughton, J. P., & Haskell, W. L. (1971). Physical activity and the prevention of coronary heart disease. Annals of Clinical Research, 3(6), 404–432.

Central

22.

Green, D. J., Maiorana, A., O'Driscoll, G., & Taylor, R. (2004). Effect of exercise training on endothelium-derived nitric oxide function in humans. The Journal of Physiology, 561(1), 1–25.

Clinical doi.org/10.1113/jphysiol.2004.068197

23.

Hawkins, S. A., & Wiswell, R. A. (2003). Rate and mechanism of maximal oxygen consumption decline with aging: Implications for exercise training. Sports Medicine, 33(12), 877–888.

Aging doi.org/10.2165/00007256-200333120-00002

24.

Heck, H., Mader, A., Hess, G., Mücke, S., Müller, R., & Hollmann, W. (1985). Justification of the 4-mmol/l lactate threshold. International Journal of Sports Medicine, 6(3), 117–130.

Thresholds doi.org/10.1055/s-2008-1025824

25.

Helgerud, J., Høydal, K., Wang, E., Karlsen, T., Berg, P., Bjerkaas, M., Simonsen, T., Helgesen, C., Hjorth, N., Bach, R., & Hoff, J. (2007). Aerobic high-intensity intervals improve VO₂max more than moderate training. Medicine & Science in Sports & Exercise, 39(4), 665–671.

Training doi.org/10.1249/mss.0b013e3180304570

26.

Hermansen, L., & Saltin, B. (1969). Oxygen uptake during maximal treadmill and bicycle exercise. Journal of Applied Physiology, 26(1), 31–37.

Testing doi.org/10.1152/jappl.1969.26.1.31

27.

Hill, A. V., & Lupton, H. (1923). Muscular exercise, lactic acid, and the supply and utilization of oxygen. QJM: An International Journal of Medicine, 16(62), 135–171.

Foundational doi.org/10.1093/qjmed/os-16.62.135

28.

Holloszy, J. O. (1967). Biochemical adaptations in muscle: Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. Journal of Biological Chemistry, 242(9), 2278–2282.

Peripheral doi.org/10.1016/S0021-9258(18)96046-1

29.

Holloszy, J. O., & Coyle, E. F. (1984). Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. Journal of Applied Physiology, 56(4), 831–838.

Peripheral doi.org/10.1152/jappl.1984.56.4.831

30.

Howley, E. T., Bassett, D. R., & Welch, H. G. (1995). Criteria for maximal oxygen uptake: Review and commentary. Medicine & Science in Sports & Exercise, 27(9), 1292–1301.

Testing doi.org/10.1249/00005768-199509000-00009

31.

Joyner, M. J., & Coyle, E. F. (2008). Endurance exercise performance: The physiology of champions. The Journal of Physiology, 586(1), 35–44.

Training doi.org/10.1113/jphysiol.2007.143834

32.

Jurca, R., Jackson, A. S., LaMonte, M. J., Morrow, J. R., Blair, S. N., Wareham, N. J., Haskell, W. L., van Mechelen, W., Church, T. S., Earnest, C. P., & Laukkanen, R. (2005). Assessing cardiorespiratory fitness without performing exercise testing. American Journal of Preventive Medicine, 29(3), 185–193.

Clinical doi.org/10.1016/j.amepre.2005.06.004

33.

Kodama, S., Saito, K., Tanaka, S., Maki, M., Yachi, Y., Asumi, M., Sugawara, A., Totsuka, K., Shimano, H., Ohashi, Y., Yamada, N., & Sone, H. (2009). Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis. JAMA, 301(19), 2024–2035.

Clinical doi.org/10.1001/jama.2009.681

34.

Kokkinos, P., Myers, J., Kokkinos, J. P., Pittaras, A., Narayan, P., Manolis, A., Karasik, P., Greenberg, M., Papademetriou, V., & Singh, S. (2008). Exercise capacity and mortality in black and white men. Circulation, 117(5), 614–622.

Clinical doi.org/10.1161/CIRCULATIONAHA.107.734764

35.

Kokkinos, P., Myers, J., Faselis, C., Panagiotakos, D. B., Doumas, M., Pittaras, A., Manolis, A., Kokkinos, J. P., Karasik, P., Greenberg, M., Papademetriou, V., & Fletcher, R. (2010). Exercise capacity and mortality in older men: A 20-year follow-up study. Circulation, 122(8), 790–797.

Clinical doi.org/10.1161/CIRCULATIONAHA.110.938852

36.

Levine, B. D., Lane, L. D., Buckey, J. C., Friedman, D. B., & Blomqvist, C. G. (1991). Left ventricular pressure-volume and Frank-Starling relations in endurance athletes: Implications for orthostatic tolerance and exercise performance. Circulation, 84(3), 1016–1023.

Central doi.org/10.1161/01.CIR.84.3.1016

37.

Lundby, C., Robach, P., & Saltin, B. (2012). The evolving science of detection of 'blood doping'. British Journal of Pharmacology, 165(5), 1306–1315.

Central doi.org/10.1111/j.1476-5381.2011.01822.x

38.

Macfarlane, D. J. (2001). Automated metabolic gas analysis systems: A review. Sports Medicine, 31(12), 841–861.

Testing doi.org/10.2165/00007256-200131120-00002

39.

Mancini, D. M., Eisen, H., Kussmaul, W., Mull, R., Edmunds, L. H., & Wilson, J. R. (1991). Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation, 83(3), 778–786.

Clinical doi.org/10.1161/01.CIR.83.3.778

40.

Mandsager, K., Harb, S., Cremer, P., Phelan, D., Nissen, S. E., & Jaber, W. (2018). Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Network Open, 1(6), e183605.

Clinical doi.org/10.1001/jamanetworkopen.2018.3605

41.

Meyer, T., Lucía, A., Earnest, C. P., & Kindermann, W. (2005). A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters—theory and application. International Journal of Sports Medicine, 26(S1), S38–S48.

Thresholds doi.org/10.1055/s-2004-830514

42.

Morganroth, J., Maron, B. J., Henry, W. L., & Epstein, S. E. (1975). Comparative left ventricular dimensions in trained athletes. Annals of Internal Medicine, 82(4), 521–524.

Central doi.org/10.7326/0003-4819-82-4-521

43.

Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E. (2002). Exercise capacity and mortality among men referred for exercise testing. New England Journal of Medicine, 346(11), 793–801.

Clinical doi.org/10.1056/NEJMoa011858

44.

Myers, J., Buchanan, N., Walsh, D., Kraemer, M., McAuley, P., Hamilton-Wessler, M., & Froelicher, V. F. (1991). Comparison of the ramp versus standard exercise protocols. Journal of the American College of Cardiology, 17(6), 1334–1342.

Testing doi.org/10.1016/S0735-1097(10)80144-5

45.

Nolan, P. B., Beaven, M. L., & Dalleck, L. (2014). Comparison of intensities and rest periods for VO₂max verification testing procedures. International Journal of Sports Medicine, 35(12), 1024–1029.

Testing doi.org/10.1055/s-0034-1367065

46.

Older, P., Smith, R., Courtney, P., & Hone, R. (1999). Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest, 116(2), 355–362.

Clinical doi.org/10.1378/chest.116.2.355

47.

Passler, S., Bohrer, J., Blöchinger, L., & Senner, V. (2019). Validity of wrist-worn activity trackers for estimating VO₂max and energy expenditure. Journal of Sports Sciences, 37(21), 2447–2456.

Wearables doi.org/10.1080/02640414.2019.1640657

48.

Paterson, D. H., Cunningham, D. A., Koval, J. J., & St. Croix, C. M. (1999). Aerobic fitness in a population of independently living men and women aged 55–86 years. Medicine & Science in Sports & Exercise, 31(12), 1813–1820.

Aging doi.org/10.1097/00005768-199912000-00018

49.

Pluim, B. M., Zwinderman, A. H., van der Laarse, A., & van der Wall, E. E. (2000). The athlete's heart: A meta-analysis of cardiac structure and function. Circulation, 101(3), 336–344.

Central doi.org/10.1161/01.CIR.101.3.336

50.

Poole, D. C., & Jones, A. M. (2017). Measurement of the maximum oxygen uptake VO₂max: VO₂peak is no longer acceptable. Journal of Applied Physiology, 122(4), 997–1002.

Testing doi.org/10.1152/japplphysiol.01063.2016

51.

Powers, S. K., Lawler, J., Dempsey, J. A., Dodd, S., & Landry, G. (1988). Effects of incomplete pulmonary gas exchange on VO₂max. Journal of Applied Physiology, 66(6), 2491–2495.

Central doi.org/10.1152/jappl.1989.66.6.2491

52.

Robergs, R. A., Dwyer, D., & Astorino, T. (2010). Recommendations for improved data processing from expired gas analysis indirect calorimetry. Sports Medicine, 40(2), 95–111.

Testing doi.org/10.2165/11319670-000000000-00000

53.

Ross, R., Blair, S. N., Arena, R., Church, T. S., Després, J. P., Franklin, B. A., Haskell, W. L., Kaminsky, L. A., Levine, B. D., Lavie, C. J., Myers, J., Niebauer, J., Sallis, R., Sawada, S. S., Sui, X., & Wisløff, U. (2016). Importance of assessing cardiorespiratory fitness in clinical practice: A case for fitness as a clinical vital sign: A scientific statement from the American Heart Association. Circulation, 134(24), e653–e699.

Clinical doi.org/10.1161/CIR.0000000000000461

54.

Saltin, B., Blomqvist, G., Mitchell, J. H., Johnson, R. L., Wildenthal, K., & Chapman, C. B. (1968). Response to exercise after bed rest and after training. Circulation, 38(5 Suppl), VII1–VII78.

Central

55.

Saltin, B., & Calbet, J. A. L. (2006). Point: In health and in a normoxic environment, VO₂max is limited primarily by cardiac output and locomotor muscle blood flow. Journal of Applied Physiology, 100(2), 744–748.

Peripheral doi.org/10.1152/japplphysiol.01395.2005

56.

Schmid, D., & Leitzmann, M. F. (2014). Cardiorespiratory fitness as predictor of cancer mortality: A systematic review and meta-analysis. Annals of Oncology, 26(2), 272–278.

Oncology doi.org/10.1093/annonc/mdu250

57.

Seiler, K. S., & Kjerland, G. Ø. (2006). Quantifying training intensity distribution in elite endurance athletes: Is there evidence for an "optimal" distribution? Scandinavian Journal of Medicine & Science in Sports, 16(1), 49–56.

Training doi.org/10.1111/j.1600-0838.2004.00418.x

58.

Sjödin, B., & Jacobs, I. (1981). Onset of blood lactate accumulation and marathon running performance. International Journal of Sports Medicine, 2(1), 23–26.

Thresholds doi.org/10.1055/s-2008-1034579

59.

Spina, R. J., Ogawa, T., Kohrt, W. M., Martin, W. H., Holloszy, J. O., & Ehsani, A. A. (1992). Differences in cardiovascular adaptations to endurance exercise training between older men and women. Journal of Applied Physiology, 75(2), 849–855.

Central doi.org/10.1152/jappl.1993.75.2.849

60.

Stöggl, T. L., & Sperlich, B. (2014). Polarized training has greater impact on key endurance variables than threshold, high intensity, or high volume training. Frontiers in Physiology, 5, 33.

Training doi.org/10.3389/fphys.2014.00033

61.

Tanaka, H., Monahan, K. D., & Seals, D. R. (2001). Age-predicted maximal heart rate revisited. Journal of the American College of Cardiology, 37(1), 153–156.

Aging doi.org/10.1016/S0735-1097(00)01054-8

62.

Taylor, H. L., Buskirk, E., & Henschel, A. (1955). Maximal oxygen intake as an objective measure of cardio-respiratory performance. Journal of Applied Physiology, 8(1), 73–80.

Testing doi.org/10.1152/jappl.1955.8.1.73

63.

Trappe, S., Hayes, E., Galpin, A., Kaminsky, L., Jemiolo, B., Fink, W., Trappe, T., Jansson, A., Gustafsson, T., & Tesch, P. (2013). New records in aerobic power among octogenarian lifelong endurance athletes. Journal of Applied Physiology, 114(1), 3–10.

Aging doi.org/10.1152/japplphysiol.01107.2012

64.

Wagner, P. D. (1996). Determinants of maximal oxygen transport and utilization. Annual Review of Physiology, 58(1), 21–50.

Foundational doi.org/10.1146/annurev.ph.58.030196.000321

65.

Wagner, P. D. (2000). New ideas on limitations to VO₂max. Exercise and Sport Sciences Reviews, 28(1), 10–14.

Foundational

66.

Wasserman, K., & McIlroy, M. B. (1964). Detecting the threshold of anaerobic metabolism in cardiac patients during exercise. The American Journal of Cardiology, 14(6), 844–852.

Thresholds doi.org/10.1016/0002-9149(64)90012-8

67.

Wasserman, K., Whipp, B. J., Koyal, S. N., & Beaver, W. L. (1973). Anaerobic threshold and respiratory gas exchange during exercise. Journal of Applied Physiology, 35(2), 236–243.

Thresholds doi.org/10.1152/jappl.1973.35.2.236

68.

Wasserman, K., Hansen, J. E., Sue, D. Y., Stringer, W. W., Sietsema, K. E., Sun, X.-G., & Whipp, B. J. (2012). Principles of Exercise Testing and Interpretation (5th ed.). Lippincott Williams & Wilkins.

Textbook

69.

Wehrlin, J. P., & Hallén, J. (2006). Linear decrease in VO₂max and performance with increasing altitude in endurance athletes. European Journal of Applied Physiology, 96(4), 404–412.

Central doi.org/10.1007/s00421-005-0081-9

70.

Whipp, B. J., Davis, J. A., & Wasserman, K. (1989). Ventilatory control of the 'isocapnic buffering' region in rapidly-incremental exercise. Respiration Physiology, 76(3), 357–367.

Thresholds doi.org/10.1016/0034-5687(89)90076-5

71.

Wisløff, U., Støylen, A., Loennechen, J. P., Bruvold, M., Rognmo, Ø., Haram, P. M., Tjønna, A. E., Helgerud, J., Slørdahl, S. A., Lee, S. J., Videm, V., Bye, A., Smith, G. L., Najjar, S. M., Ellingsen, Ø., & Skjærpe, T. (2007). Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation, 115(24), 3086–3094.

Training doi.org/10.1161/CIRCULATIONAHA.106.675041